Impact and Effectiveness of Monovalent Rotavirus Vaccine Against Severe Rotavirus Diarrhea in Ghana

Clinical Infectious Diseases

Volumn 62, Issue , 2016, Pages S200-S207

  Armah, George ^a   Pringle, Kimberly ^b   Enweronu Laryea, Christabel C ^c   Ansong, Daniel ^d   Mwenda, Jason M ^e   Diamenu, Stanley K ^e   Narh, Clement ^a,f   Lartey, Belinda ^a   Binka, Fred ^f   Grytdal, Scott ^b   Patel, Manish ^b   Parashar, Umesh ^b   Lopman, Ben ^b  

^a University of Ghana   (Ghana)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c UNIVERSITY OF GHANA   (Ghana)

^d KOMFO ANOKYE TEACHING HOSPITAL   (Ghana)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

^f UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Ghana)

Author keywords

vaccine effectiveness

Indexed keywords

ROTAVIRUS VACCINE; LIVE VACCINE; RIX4414 VACCINE; VACCINE;

ARTICLE; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; GHANA; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFANT; INFECTIOUS DIARRHEA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; ROTAVIRUS INFECTION; TEACHING HOSPITAL; TIME SERIES ANALYSIS; TREND STUDY; VACCINATION; ACUTE DISEASE; DIARRHEA; EPIDEMIOLOGICAL MONITORING; GASTROENTERITIS; IMMUNIZATION; IMMUNOLOGY; PREVENTIVE HEALTH SERVICE; ROTAVIRUS INFECTIONS; STATISTICAL MODEL; VIROLOGY;

ACUTE DISEASE; CHILD, PRESCHOOL; DIARRHEA; EPIDEMIOLOGICAL MONITORING; FEMALE; GASTROENTERITIS; GHANA; HOSPITALIZATION; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION SCHEDULE; INFANT; LOGISTIC MODELS; MALE; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; VACCINATION; VACCINE POTENCY; VACCINES, ATTENUATED;

EID: 84965137925     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciw014     Document Type: Article

References (20)

1. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 385:117-71.
2. World Health Organization. Immunization, vaccines and biologicals. Geneva, Switzerland: WHO, 2010.
3. Armah GE, Sow SO, Breiman RF, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: A randomised, double-blind, placebo-controlled trial. Lancet 2010; 376:606-14.
4. Steele AD, Neuzil KM, Cunliffe NA, et al. Human rotavirus vaccine Rotarix provides protection against diverse circulating rotavirus strains in African infants: A randomized controlled trial. BMC Infect Dis 2012; 12:213.
5. Cortese MM, Immergluck LC, Held M, et al. Effectiveness of monovalent and pentavalent rotavirus vaccine. Pediatrics 2013; 132:e25-33.
6. Payne DC, Boom JA, Staat MA, et al. Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011. Clin Infect Dis 2013; 57:13-20.
7. Groome MJ, Page N, Cortese MM, et al. Effectiveness of monovalent human rotavirus vaccine against admission to hospital for acute rotavirus diarrhoea in South African children: A case-control study. Lancet Infect Dis 2014; 14: 1096-104.
8. de Palma O, Cruz L, Ramos H, et al. Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study. BMJ 2010; 340: c2825.
9. Patel M, Pedreira C, De Oliveira LH, et al. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. JAMA 2009; 301:2243-51.
10. Mukaratirwa A, Berejena C, Nziramasanga P, et al. Epidemiologic and genotypic characteristics of rotavirus strains detected in children less than 5 years of age with gastroenteritis treated at 3 pediatric hospitals in Zimbabwe during 2008-2011. Pediatr Infect Dis J 2014; 33(suppl 1):S45-8.
11. Tsolenyanu E, Seheri M, Dagnra A, et al. Surveillance for rotavirus gastroenteritis in children less than 5 years of age in Togo. Pediatr Infect Dis J 2014; 33(suppl 1): S14-8.
12. Gavi, the Vaccine Alliance. Ghana Gavi country hub 2015. Available at: http://www.gavi.org/country/ghana/. Accessed 6 October 2015.
13. World Health Organization. Generic protocols for (i) hospital-based surveillance to estimate the burden of rotavirus gastroenteritis in children and (ii) a community-based survey on utilization of health care services for gastroenteritis in children: field test version. Available at: http://www.who.int/immunization/diseases/rotavirus/generic-protocols/en/. Accessed 6 October 2015.
14. Hosmer DW, Lemeshow S. Applied logistic regression. 2nd ed. New York: Wiley; 2000. xii, 373.
15. Ruuska T, Vesikari T. Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes. Scand J Infect Dis 1990; 22:259-67.
16. Soares-Weiser K, Maclehose H, Bergman H, et al. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Syst Rev 2012; 11: CD008521.
17. Madhi SA, Cunliffe NA, Steele D, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med 2010; 362:289-98.
18. Bar-Zeev N, Kapanda L, Tate JE, et al. Effectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: an observational and case-control study. Lancet Infect Dis 2015; 15:422-8.
19. Msimang VM, Page N, Groome MJ, et al. Impact of rotavirus vaccine on childhood diarrheal hospitalization after introduction into the South African public immunization program. Pediatr Infect Dis J 2013; 32:1359-64.
20. Enweronu-Laryea CC, Boamah I, Sifah E, Diamenu SK, Armah G. Decline in severe diarrhea hospitalizations after the introduction of rotavirus vaccination in Ghana: A prevalence study. BMC Infect Dis 2014; 14:431.